The future of genomic testing in primary care: the changing face of personalized medicine

Personalized Medicine
Gillian BartlettAmalia M Issa

Abstract

Primary care is recognized worldwide as a key component for improving health outcomes in the population. At the same time, healthcare systems are rapidly changing with increasing expectations from technological advances. Genomics is a major driver in changing how medicine is being practiced; however, the importance for primary care has been under-appreciated. Strategically implementing genomics in a way that accounts for the unique characteristics of the primary care context is essential. In this perspective, we present important areas that we believe are critical in consideration of both the future of genomic medicine and primary healthcare delivery.

References

Oct 22, 1994·Lancet·B Starfield
Jan 8, 1994·Health Policy·J Frenk
Mar 4, 2000·Women's Health Issues : Official Publication of the Jacobs Institute of Women's Health·S H ScholleJ Binko
Aug 31, 2000·Academic Medicine : Journal of the Association of American Medical Colleges·R T ActonL Leviton
Oct 6, 2000·Clinical Pharmacokinetics·G Cheymol
Jan 31, 2002·Health Affairs·E H WagnerA Bonomi
Mar 23, 2002·The Pharmacogenomics Journal·P J Wedlund, J de Leon
Jul 18, 2002·Nature Reviews. Drug Discovery·Amalia M Issa
Feb 6, 2003·American Journal of Preventive Medicine·Janet Audrain-McGovernFreda Patterson
Jun 24, 2003·The American Journal of Gastroenterology·Adam F BarrisonPaul C Schroy
Apr 16, 2004·Annals of Family Medicine·Robert GramlingLarry Culpepper
Nov 24, 2004·The American Journal of Geriatric Pharmacotherapy·Emily R HajjarKenneth E Schmader
May 13, 2005·International Journal of Obesity : Journal of the International Association for the Study of Obesity·R L NewtonD Williamson
Oct 6, 2005·The Milbank Quarterly·Barbara StarfieldJames Macinko
Nov 9, 2005·Transactions of the Royal Society of Tropical Medicine and Hygiene·Abdesslam Boutayeb
Nov 22, 2005·Pharmacology & Therapeutics·Stephanie A Shore, Richard A Johnston
Dec 16, 2005·Pharmacogenomics·Gloria R GriceHoward L McLeod
Jan 11, 2007·Journal of the American Medical Informatics Association : JAMIA·Jerome A OsheroffDon E Detmer
Jan 24, 2007·Biological Psychiatry·Stefan KloiberSusanne Lucae
Aug 23, 2007·BMC Health Services Research·Dinny H de BakkerPeter P Groenewegen
Oct 24, 2007·Annals of Medicine·Bahram Jafar-Mohammadi, Mark I McCarthy
Dec 13, 2007·Genetics in Medicine : Official Journal of the American College of Medical Genetics·Muin J KhouryLinda Bradley
May 27, 2008·Journal of the International Society of Sports Nutrition·Colin WilbornRichard Kreider
Jul 25, 2008·The New England Journal of Medicine·UNKNOWN SEARCH Collaborative GroupR Collins
Aug 30, 2008·Journal of the American Medical Informatics Association : JAMIA·David C KaelberDavid W Bates
Oct 15, 2008·Human Molecular Genetics·Douglas F Easton, Rosalind A Eeles
Nov 21, 2008·The New England Journal of Medicine·James B MeigsL Adrienne Cupples
Feb 21, 2009·The New England Journal of Medicine·UNKNOWN International Warfarin Pharmacogenetics ConsortiumJ A Johnson
May 23, 2009·American Journal of Preventive Medicine·Suzanne M O'NeillUNKNOWN Family Healthware Impact Trial group
May 30, 2009·Genetics in Medicine : Official Journal of the American College of Medical Genetics·Morris W FosterRichard R Sharp
Oct 15, 2009·Annual Review of Medicine·Darren L RobertsAndrew G Renehan
Jun 17, 2010·The New England Journal of Medicine·Margaret A Hamburg, Francis S Collins
Sep 8, 2010·The Journal of Allergy and Clinical Immunology·Erik MelénJessica Lasky-Su
Oct 20, 2010·Journal of the National Cancer Institute·Matthew E MealiffeDavid A Hinds
Nov 26, 2010·Circulation·Philip GreenlandUNKNOWN American College of Cardiology Foundation/American Heart Asscoiation Tasl Force on Practice Guidelines
Feb 1, 2011·Arthritis and Rheumatism·Ruth KlaasenPaul P Tak
Mar 23, 2011·Expert Opinion on Drug Metabolism & Toxicology·Glynn A MorrishBruce Green
Jul 29, 2011·Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology·Muin J KhourySheri D Schully
Nov 15, 2011·Genetics in Medicine : Official Journal of the American College of Medical Genetics·Wendy S RubinsteinUNKNOWN Family Healthware Impact Trial (FHITr) Group
Apr 3, 2012·Pharmacogenomics·Jesse J Swen, Henk Jan Guchelaar
Apr 4, 2012·Annals of Allergy, Asthma & Immunology : Official Publication of the American College of Allergy, Asthma, & Immunology·William J Anderson, Brian J Lipworth

❮ Previous
Next ❯

Citations

Feb 28, 2018·Public Health Reviews·Kevin SelbyJacques Cornuz
Aug 29, 2014·Journal of Translational Medicine·Vasiliki Rahimzadeh, Gillian Bartlett
Dec 2, 2015·Genome Génome / Conseil National De Recherches Canada·Naazish S Bashir, Wendy J Ungar
Feb 14, 2021·Current Opinion in Biotechnology·Ruby Cy LinUNKNOWN Australian Phage Biobanking Network

❮ Previous
Next ❯

Methods Mentioned

BETA
genotyping

Software Mentioned

Hughes Risk Apps
Health Heritage
Family Healthware
MeTree

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.

Related Papers

Physician Executive
Joseph Barone, Shirley Shmerling
Healthcare Financial Management : Journal of the Healthcare Financial Management Association
R A Averill, M J Kalison
Hospitals & Health Networks
Cynthia Hedges Greising
© 2022 Meta ULC. All rights reserved